What does CUSIP G0750W203 represent in this 13F holders report?

CUSIP G0750W203 is the security identifier for AXGT - AXOVANT GENE THERAPIES LTD - COM used to aggregate holder disclosures.

How many institutions held AXGT - AXOVANT GENE THERAPIES LTD - COM in Q1 2019?

2 institutional investors reported AXGT - AXOVANT GENE THERAPIES LTD - COM for Q1 2019. Use the holders table for investor-level position and value details.

AXOVANT GENE THERAPIES LTD - COM (AXGT)

CUSIP: G0750W203

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class: Equity / COM
Total 13F shares: 216,596
Share change: +216,596
Total reported value: $288,000
Price per share: $1.35
Number of holders: 2
Value change: +$288,005
Number of buys: 2

Quarterly Holders Quick Answers

What is CUSIP G0750W203?
CUSIP G0750W203 identifies AXGT - AXOVANT GENE THERAPIES LTD - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2019

Recent filing periods for CUSIP G0750W203:

Q4 2020 Q3 2020 Q2 2020 Q1 2020 Q4 2019 Q3 2019 Q2 2019 Q1 2019

Institutional Holders of AXOVANT GENE THERAPIES LTD - COM (AXGT) as of Q1 2019

As of 31 Mar 2019, AXOVANT GENE THERAPIES LTD - COM (AXGT) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 216,596 shares. The largest 2 holders included MARSHALL WACE, LLP and Marshall Wace North America L.P.. This page lists 2 institutional shareholders reporting positions in this security for the Q1 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.